Organon & Co.

14.52
-0.04 (-0.27%)
At close: Mar 28, 2025, 3:59 PM
14.47
-0.31%
After-hours: Mar 28, 2025, 06:31 PM EDT

Organon & Co. Statistics

Share Statistics

Organon & Co. has 257.95M shares outstanding. The number of shares has increased by 0.74% in one year.

Shares Outstanding 257.95M
Shares Change (YoY) 0.74%
Shares Change (QoQ) 0.03%
Owned by Institutions (%) 80.07%
Shares Floating 257.25M
Failed to Deliver (FTD) Shares 598
FTD / Avg. Volume 0.02%

Short Selling Information

The latest short interest is 18.23M, so 7.08% of the outstanding shares have been sold short.

Short Interest 18.23M
Short % of Shares Out 7.08%
Short % of Float 7.09%
Short Ratio (days to cover) 4.12

Valuation Ratios

The PE ratio is 4.44 and the forward PE ratio is 3.92. Organon & Co.'s PEG ratio is -0.27.

PE Ratio 4.44
Forward PE 3.92
PS Ratio 0.6
Forward PS 0.6
PB Ratio 8.13
P/FCF Ratio 5.02
PEG Ratio -0.27
Financial Ratio History

Enterprise Valuation

Organon & Co. has an Enterprise Value (EV) of 11.75B.

EV / Earnings 13.6
EV / Sales 1.83
EV / EBITDA 7.32
EV / EBIT 7.91
EV / FCF 15.38

Financial Position

The company has a current ratio of 1.6, with a Debt / Equity ratio of 18.81.

Current Ratio 1.6
Quick Ratio 1.11
Debt / Equity 18.81
Total Debt / Capitalization 94.95
Cash Flow / Debt 0.11
Interest Coverage 2.86

Financial Efficiency

Return on equity (ROE) is 1.83% and return on capital (ROIC) is 17.01%.

Return on Equity (ROE) 1.83%
Return on Assets (ROA) 0.07%
Return on Capital (ROIC) 17.01%
Revenue Per Employee $640,300
Profits Per Employee $86,400
Employee Count 10,000
Asset Turnover 0.49
Inventory Turnover 2.03

Taxes

Income Tax -57M
Effective Tax Rate -0.07

Stock Price Statistics

The stock price has increased by -22.5% in the last 52 weeks. The beta is 0.72, so Organon & Co.'s price volatility has been higher than the market average.

Beta 0.72
52-Week Price Change -22.5%
50-Day Moving Average 15.37
200-Day Moving Average 17.76
Relative Strength Index (RSI) 41.13
Average Volume (20 Days) 3.33M

Income Statement

In the last 12 months, Organon & Co. had revenue of 6.4B and earned 864M in profits. Earnings per share was 3.36.

Revenue 6.4B
Gross Profit 3.71B
Operating Income 1.49B
Net Income 864M
EBITDA 1.6B
EBIT 1.49B
Earnings Per Share (EPS) 3.36
Full Income Statement

Balance Sheet

The company has 675M in cash and 8.88B in debt, giving a net cash position of -8.21B.

Cash & Cash Equivalents 675M
Total Debt 8.88B
Net Cash -8.21B
Retained Earnings 1.01B
Total Assets 13.1B
Working Capital 1.63B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 939M and capital expenditures -175M, giving a free cash flow of 764M.

Operating Cash Flow 939M
Capital Expenditures -175M
Free Cash Flow 764M
FCF Per Share 2.97
Full Cash Flow Statement

Margins

Gross margin is 58.02%, with operating and profit margins of 23.21% and 13.49%.

Gross Margin 58.02%
Operating Margin 23.21%
Pretax Margin 12.6%
Profit Margin 13.49%
EBITDA Margin 25.05%
EBIT Margin 23.21%
FCF Margin 11.93%

Dividends & Yields

OGN pays an annual dividend of $1.4, which amounts to a dividend yield of 7.43%.

Dividend Per Share $1.40
Dividend Yield 7.43%
Dividend Growth (YoY) 0%
Payout Ratio 42.04%
Earnings Yield 23.06%
FCF Yield 20.33%
Dividend Details

Analyst Forecast

The average price target for OGN is $20, which is 37.3% higher than the current price. The consensus rating is "Hold".

Price Target $20
Price Target Difference 37.3%
Analyst Consensus Hold
Analyst Count 5
Stock Forecasts

Scores

Altman Z-Score 1.28
Piotroski F-Score 5